日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Programmed death-1 inhibition increases vaccine-induced T-cell infiltration in patients with prostate cancer.

程序性死亡受体1抑制剂可增加前列腺癌患者体内疫苗诱导的T细胞浸润

Lassoued Wiem, Madan Ravi A, Xue Elisabetta, Burnett Daniel, Canubas Kenneth D, Bailey Shania, Marté Jennifer L, Tsai Yo-Ting, Donahue Renee N, Turkbey Ismail Baris, Papanicolau-Sengo Antonios, Williams Moniquea, Hankin Amy, Manukyan Manuk, Manu Michell, Kang Zhigang, Pritchard Colin, Dahut William, Karzai Fatima, Schlom Jeffrey, Sater Sam, Pinto Peter, Gulley James L

Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade

接受免疫检查点阻断治疗的非小细胞肺癌患者的血液生物标志物

Tsai, Yo-Ting; Schlom, Jeffrey; Donahue, Renee N

Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer

针对TGF-β和PD-L1的双功能融合蛋白bintrafusp alfa在晚期非小细胞肺癌患者中的疗效、安全性和生物标志物分析

Rajan, Arun; Abdul Sater, Houssein; Rahma, Osama; Agajanian, Richy; Lassoued, Wiem; Marté, Jennifer L; Tsai, Yo-Ting; Donahue, Renee N; Lamping, Elizabeth; Bailey, Shania; Weisman, Andrew; Walter-Rodriguez, Beatriz; Ito, Rena; Vugmeyster, Yulia; Sato, Masashi; Machl, Andreas; Schlom, Jeffrey; Gulley, James L

A T cell receptor β chain-directed antibody fusion molecule activates and expands subsets of T cells to promote antitumor activity

AT细胞受体β链导向的抗体融合分子激活并扩增T细胞亚群,从而促进抗肿瘤活性。

Hsu, Jonathan; Donahue, Renee N; Katragadda, Madan; Lowry, Jessica; Huang, Wei; Srinivasan, Karunya; Guntas, Gurkan; Tang, Jian; Servattalab, Roya; Moisan, Jacques; Tsai, Yo-Ting; Stoop, Allart; Palakurthi, Sangeetha; Chopra, Raj; Liu, Ke; Wherry, E John; Su, Zhen; Gulley, James L; Bayliffe, Andrew; Schlom, Jeffrey

First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma

M9241 (NHS-IL12) 联合avelumab治疗晚期实体瘤患者的首次人体Ib期试验,包括在晚期尿路上皮癌患者中进行剂量扩展。

Strauss, Julius; Deville, Jean-Laurent; Sznol, Mario; Ravaud, Alain; Maruzzo, Marco; Pachynski, Russell K; Gourdin, Theodore S; Maio, Michele; Dirix, Luc; Schlom, Jeffrey; Donahue, Renee N; Tsai, Yo-Ting; Wang, XiaoZhe; Vugmeyster, Yulia; Beier, Frank; Seebeck, Joerg; Schroeder, Andreas; Chennoufi, Sarah; Gulley, James L

Immune correlates of clinical parameters in patients with HPV-associated malignancies treated with bintrafusp alfa

接受 bintrafusp alfa 治疗的 HPV 相关恶性肿瘤患者的临床参数的免疫相关性

Tsai, Yo-Ting; Strauss, Julius; Toney, Nicole J; Jochems, Caroline; Venzon, David J; Gulley, James L; Schlom, Jeffrey; Donahue, Renee N

Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors

胸腺上皮肿瘤患者接受免疫检查点抑制剂治疗后以关节为主的风湿性并发症

Mullenix, Cristina; Ballman, Madison; Chen, Haobin; Swift, Shannon; McAdams, Meredith J; Tsai, Yo-Ting; Donahue, Renee N; Poretta, Trina; Gupta, Sarthak; Loehrer, Patrick J; Schlom, Jeffrey; Gulley, James L; Rajan, Arun

A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer

一项随机 II 期临床试验,比较 mFOLFOX6 联合贝伐珠单抗单药治疗或联合 AdCEA 疫苗 + 阿维鲁单抗免疫疗法治疗未经治疗的转移性结直肠癌的疗效

Redman, Jason M; Tsai, Yo-Ting; Weinberg, Benjamin A; Donahue, Renee N; Gandhy, Shruti; Gatti-Mays, Margaret E; Abdul Sater, Houssein; Bilusic, Marijo; Cordes, Lisa M; Steinberg, Seth M; Marte, Jennifer L; Jochems, Caroline; Kim, Sunnie S; Marshall, John L; McMahon, Sheri; Redmond, Erica; Schlom, Jeffrey; Gulley, James L; Strauss, Julius

Segregating Suspected Child Maltreatment from Non-Child Maltreatment Injuries: A Population-Based Case-Control Study in Taiwan

台湾一项基于人群的病例对照研究:区分疑似虐待儿童与非虐待儿童造成的伤害

Jin, Yo-Ting; Chen, Chin-Mi; Huang, Yao-Ching; Chung, Chi-Hsiang; Sun, Chien-An; Huang, Shi-Hao; Chien, Wu-Chien; Wu, Gwo-Jang

Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)

针对转移性去势抵抗性前列腺癌 (mCRPC) 患者的多靶点重组 Ad5 PSA/MUC-1/brachyury 免疫疗法疫苗的 I 期研究

Bilusic, Marijo; McMahon, Sheri; Madan, Ravi A; Karzai, Fatima; Tsai, Yo-Ting; Donahue, Renee N; Palena, Claudia; Jochems, Caroline; Marté, Jennifer L; Floudas, Charalampos; Strauss, Julius; Redman, Jason; Abdul Sater, Houssein; Rabizadeh, Shahrooz; Soon-Shiong, Patrick; Schlom, Jeffrey; Gulley, James L